Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20171
20204
20211
20226
20241
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting10
Active, not recruiting6
Terminated4
Completed2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
BioNTech SE2
Amgen1
Aminex Therapeutics, Inc.1
Aulos Bioscience, Inc.1
Basilea Pharmaceutica1
Bolt Biotherapeutics, Inc.1
Bristol-Myers Squibb1
DualityBio Inc.1
EMD Serono Research & Development Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms23
Carcinoma, Non-Small-Cell Lung16
Melanoma10
Colorectal Neoplasms9
Breast Neoplasms8
Ovarian Neoplasms8
Carcinoma, Renal Cell7
Endometrial Neoplasms7
Squamous Cell Carcinoma of Head and Neck7
Urinary Bladder Neoplasms6

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.